業績

Izuka S, Umezawa N, Komai T, Sugimori Y, Kimura N, Mizoguchi F, Fujieda Y, Ninagawa K, Iwasaki T, Suzuki K, Takeuchi T, Ohmura K, Mimori T, Atsumi T, Kawakami E, Suzuki A, Kochi Y, Yamamoto K, Yasuda S, Okamura T, Ota M, Fujio K The muscle tissue transcriptome of idiopathic inflammatory myopathy reflects the muscle damage process by monocytes and presence of skin lesions.

Arthritis & Rheumatology

IF:10.995

  • 2024
  • 膠原病グループ
  • 欧文論文/原著

Kidoguchi G, Yoshida Y, Watanabe H, Sugimoto T, Mokuda S, Kida T, Yajima N, Omura S, Nakagomi D, Abe Y, Kadoya M, Takizawa N, Nomura A, Kukida Y, Kondo N, Yamano Y, Yanagida T, Endo K, Matsui K, Takeuchi T, Ichinose K, Kato M, Yanai R, Matsuo Y, Shimojima Y, Nishioka R, Okazaki R, Takata T, Ito T, Moriyama M, Takatani A, Miyawaki Y, Ito-Ihara T, Kawaguchi T, Kawahito Y, Hirata S.

Effectiveness and safety of rituximab in severely relapsed antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective analysis of a Japanese multicentre cohort from the J-CANVAS. Clinical Rheumatology. in press.

IF:2.9

  • 2024
  • 膠原病グループ
  • 欧文論文/原著

Takeyama S, Kono M, Aso K, Kamada K, Tada M, Tarumi M, Kosumi Y, Yoshimura M, Ninagawa K, Hisada R, Fujieda Y, Kato M, Amengual O, Atsumi T.

Relation between hydroxychloroquine dose and continuation rate in patients with systemic lupus erythematosus.

Modern Rheumatology. in press.

IF: 2.2

  • 2024
  • 膠原病グループ
  • 欧文論文/原著

Zhao D, Han C, Mammadova-Bach E, Watanabe-Kusunoki K, Bandeira Honda TS, Li Y, Li C, Li Q, Long H, Lyubenov L, Shi C, Boor P, Droste P, Parikh S, Shapiro J, Chiara L, Carangelo G, Romagnani P, Klussmann S, Vater A, Anders HJ.

Inhibition of complement factor C5a or C5aR for cholesterol crystal embolism-related microvascular thrombosis and its consequences.

Kidney International, in press

IF: 14.8

  • 2024
  • 腎臓グループ
  • 欧文論文/原著

Oe Y, Nomoto H, Cho KY, Yokozeki K, Ono T, Miya A, Kameda H, Nakamura A, Arimura Y, Atsumi T. Efficacy and safety of oral semaglutide in older patients with type 2 diabetes: a retrospective observational study (the OTARU-SEMA study).

BMC Endocr Disord. in press

IF: 2.8

  • 2024
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Takahashi-Kobayashi M, Sada KE, Kawashima S, Miyawaki Y, Nakazawa D, Furuichi K, Okada H, Narita I, Usui J.

Survey of Japanese nephrologists' use of clinical practice guidelines for rapidly progressive glomerulonephritis.

Clin Exp Nephrol. 2024 Apr;28(4):316-324.

IF 2.2

  • 2024
  • 腎臓グループ
  • 欧文論文/原著

Yuka Nishibata, Suishin Arai, Mai Taniguchi, Issei Nakade, Hodaka Ogawa, Shota Kitano, Yumeka Hosoi, Ayano Shindo, Ryo Nishiyama, Sakiko Masuda, Daigo Nakazawa, Utano Tomaru, Takafumi Shimizu, William Sinko, Tadashi Nagakura, Yoh Terada, and Akihiro Ishizu.

Cathepsin C inhibition reduces neutrophil serine protease activity and improves activated neutrophil-mediated disorders.

Nature Communications , in press

IF 14.7

  • 2024
  • 腎臓グループ
  • 欧文論文/原著

The Best Doctors in Japan 2024-2025  加藤 将先生

  • 2024
  • 膠原病グループ
  • 受賞

Maiko Miyamoto, Akinobu Nakamura, Aika Miya, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, Naoya Iwahara, Kiyohiko Hotta, Nobuo Shinohara, Tatsuya Atsumi.

Normalization of impaired glucose tolerance after kidney transplantation is associated with improved beta-cell function.

Am J Physiol Endocrinol Metab, in press.

IF 5.1

  • 2024
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Okino T, Ou Y, Ikebe M, Furusaki A, Sagawa A, Kato M, Atsumi T, Sutherland K, Kamishima T.

Subtle radiographic progression at six months can be detected using automated quantitative software in rheumatoid arthritis while receiving tocilizumab.

Modern Rheumatology. in press.

IF:2.2

  • 2024
  • 膠原病グループ
  • 欧文論文/原著